Health-related quality of life in patients with high-risk melanoma randomised in the Nordic phase 3 trial with adjuvant intermediate-dose interferon alfa-2b
2012 ◽
Vol 48
(13)
◽
pp. 2012-2019
◽
Keyword(s):
Phase 3
◽
2011 ◽
Vol 29
(15_suppl)
◽
pp. 8547-8547
Keyword(s):
2007 ◽
Vol 6
(2)
◽
pp. 238
◽
Keyword(s):